Aspen Pharmacare
(OTC) APNHY
Aspen Pharmacare Financials at a Glance
Market Cap
$4.18B
Revenue (TTM)
ZAR 83.20B
Net Income (TTM)
ZAR 2.41B
EPS (TTM)
-$0.23
P/E Ratio
-40.11
Dividend
$0.12
Beta (Volatility)
0.34 (Low)
Dividend
$0.12
Beta (Volatility)
0.34 (Low)
Price
$9.41
Volume
192
Open
$9.41
Price
$9.41
Volume
192
Open
$9.41
Previous Close
$9.41
Daily Range
$9.41 - $9.41
52-Week Range
$5.24 - $9.41
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.12
Beta (Volatility)
0.34 (Low)
Price
$9.41
Volume
192
Open
$9.41
Previous Close
$9.41
Daily Range
$9.41 - $9.41
52-Week Range
$5.24 - $9.41
Estimated Earnings Date
Sep 2, 2026
APNHY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aspen Pharmacare
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,557
CEO
Stephen Bradley Saad, PhD
Website
www.aspenpharma.comHeadquarters
Durban, GP 2191, ZA
APNHY Financials
Key Financial Metrics (TTM)
Gross Margin
41.91%
Operating Margin
16.01%
Net Income Margin
-5.19%
Return on Equity
-2.41%
Return on Capital
1.19%
Return on Assets
-1.56%
Earnings Yield
-2.49%
Dividend Yield
1.30%
Payout Ratio
-47.07%
Stock Overview
Market Cap
$4.18B
Shares Outstanding
444.02M
Volume
192
Avg. Volume
207.476
Financials (TTM)
Gross Profit
ZAR 36.33B
Operating Income
ZAR 9.52B
EBITDA
ZAR 12.40B
Operating Cash Flow
ZAR 12.33B
Capital Expenditure
-ZAR 5.28B
Free Cash Flow
ZAR 7.06B
Cash & ST Invst.
ZAR 5.61B
Total Debt
ZAR 32.91B
Aspen Pharmacare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
ZAR 16.27B
-23.0%
Gross Profit
ZAR 7.10B
-23.8%
Gross Margin
43.64%
N/A
Market Cap
$4.18B
N/A
Market Cap/Employee
$451.12K
N/A
Employees
9,262
N/A
Net Income
ZAR 1.40B
-39.4%
EBITDA
ZAR 3.87B
-12.9%
Quarterly Fundamentals
Total Cash
ZAR 5.61B
-51.6%
Total Debt
ZAR 32.91B
-8.9%
Accounts Receivable
ZAR 10.07B
+1010.1%
Inventory
ZAR 15.44B
-18.5%
Long Term Debt
ZAR 29.31B
+19.5%
Short Term Debt
ZAR 3.60B
-68.9%
Return on Assets
-1.56%
N/A
Return on Invested Capital
5.49%
N/A
Free Cash Flow
ZAR 2.33B
+141.5%
Operating Cash Flow
ZAR 3.41B
+38.6%